These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8740088)

  • 21. Effect of serotonin (5-HT)3-receptor antagonists YM060, YM114 (KAE-393), ondansetron and granisetron on 5-HT4 receptors and gastric emptying in rodents.
    Miyata K; Yamano M; Kamato T; Akuzawa S
    Jpn J Pharmacol; 1995 Nov; 69(3):205-14. PubMed ID: 8699628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzoxazole derivatives as novel 5-HT3 receptor partial agonists in the gut.
    Sato Y; Yamada M; Yoshida S; Soneda T; Ishikawa M; Nizato T; Suzuki K; Konno F
    J Med Chem; 1998 Jul; 41(16):3015-21. PubMed ID: 9685241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist.
    Nagakura Y; Kadowaki M; Tokoro K; Tomoi M; Mori J; Kohsaka M
    J Pharmacol Exp Ther; 1993 May; 265(2):752-8. PubMed ID: 8496821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptors.
    Yang D; Soulier JL; Sicsic S; Mathé-Allainmat M; Brémont B; Croci T; Cardamone R; Aureggi G; Langlois M
    J Med Chem; 1997 Feb; 40(4):608-21. PubMed ID: 9046352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participation of a cholinergic mechanism in 5-hydroxytryptamine (5-HT)3 and 5-HT4 receptor-mediated stimulation of gastric emptying in rats.
    Yamano M; Kamato T; Miyata K
    Arzneimittelforschung; 1997 Nov; 47(11):1242-6. PubMed ID: 9428982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New benzimidazole derivatives: selective and orally active 5-HT3 receptor antagonists.
    Pascual D; Girón R; Alsasua A; Benhamú B; López-Rodríguez ML; Martín MI
    Eur J Pharmacol; 2003 Feb; 462(1-3):99-107. PubMed ID: 12591101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
    Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
    J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonistic activities of N-3389, a newly synthesized diazabicyclo derivative, at 5-HT3 and 5-HT4 receptors.
    Hagihara K; Hayakawa T; Arai T; Eguchi H; Mino S; Kawase S
    Eur J Pharmacol; 1994 Dec; 271(1):159-66. PubMed ID: 7698198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GYKI-46 903, a non-competitive antagonist for 5-HT3 receptors.
    Csillik-Perczel V; Bakonyi A; Yemane T; Vitalis B; Horvath E; Solyom S; Szekely JI; Harsing LG
    Pharmacol Toxicol; 1996 Jul; 79(1):32-9. PubMed ID: 8841094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (R) and (S) RS 56532: mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selectivity.
    Eglen RM; Bonhaus DW; Clark RD; Johnson LG; Lee CH; Leung E; Smith WL; Wong EH; Whiting RL
    Neuropharmacology; 1994; 33(3-4):515-26. PubMed ID: 7984291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New 2-piperazinylbenzimidazole derivatives as 5-HT3 antagonists. Synthesis and pharmacological evaluation.
    Orjales A; Mosquera R; Labeaga L; Rodes R
    J Med Chem; 1997 Feb; 40(4):586-93. PubMed ID: 9046349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high 5-HT2A receptor affinity.
    Pertz HH; Milhahn H; Eich E
    J Med Chem; 1999 Feb; 42(4):659-68. PubMed ID: 10052973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets.
    Endo T; Ogawa T; Hamaue N; Akita K; Hirafuji M; Minami M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):243-53. PubMed ID: 9730004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological analyses of endo-6-methoxy-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-2,3-dihydro-2-oxo-1 H- benzimidazole-1-carboxylate hydrochloride (DAU 6285) at the 5-hydroxytryptamine4 receptor in the tunica muscularis mucosae of rat esophagus and ileum of guinea pig: role of endogenous 5-hydroxytryptamine.
    Waikar MV; Hegde SS; Ford AP; Clarke DE
    J Pharmacol Exp Ther; 1993 Feb; 264(2):654-61. PubMed ID: 8437113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinoxalin-2-carboxamides: synthesis and pharmacological evaluation as serotonin type-3 (5-HT3) receptor antagonists.
    Mahesh R; Devadoss T; Pandey DK; Yadav SK
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):610-5. PubMed ID: 21222509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ginger constituents on the gastrointestinal tract: role of cholinergic M3 and serotonergic 5-HT3 and 5-HT4 receptors.
    Pertz HH; Lehmann J; Roth-Ehrang R; Elz S
    Planta Med; 2011 Jul; 77(10):973-8. PubMed ID: 21305447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of 5-hydroxykynurenamine, L-kynurenine and kynuramine with multiple serotonin receptors in smooth muscle.
    Pomfret DW; Schenck KW; Fludzinski P; Cohen ML
    J Pharmacol Exp Ther; 1987 May; 241(2):465-71. PubMed ID: 3572806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.